Heron Therapeutics (HRTX) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Heron Therapeutics (HRTX) reported $40.78 million in revenue for the quarter ended December 2024, representing a year-over-year increase of 19.1$0.02 for the same period compares to -$0.07 a year ago.The reported revenue compares to the Zacks Consensus Estimate of$36.95 million, representing a surprise of +10.37%. The company delivered an EPS surprise of +166.67%, with the consensus EPS estimate being -$0.03.While investors closely watch year-over-year changes in headline numbers -- revenue and e ...